Search research articles
Contact Us
Filters
Showing results (191-200 of 207) with videos related to
Page
of 21
Sort By:
Arthritis and Rheumatism
|
January 22, 2013
Rituximab therapy for primary Sjögren's syndrome: an open-label clinical trial and mechanistic analysis
E William St Clair, Marc C Levesque, Eline T Luning Prak, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 4, 2012
Phosphorylation of CRTC3 by the salt-inducible kinases controls the interconversion of classically activated and regulatory macrophages
Kristopher Clark, Kirsty F MacKenzie, Kasparas Petkevicius, et al.
Chemical Biology & Drug Design
|
June 11, 2013
TAK1 inhibition in the DFG-out conformation
Iain Kilty, Martin P Green, Andrew S Bell, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 27, 2012
Synthesis and structure-activity relationships of a novel series of pyrimidines as potent inhibitors of TBK1/IKKε kinases
Edward G McIver, Justin Bryans, Kristian Birchall, et al.
Journal of the American Chemical Society
|
October 22, 2025
Baited SELEX: Drug-Directed Selection of Aptamers to PSMA for <i>In Vivo</i> Targeting of Prostate Cancer Xenografts in Mice
Kun Liu, Nicole Robinson, Emirhan Tekoglu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 10, 2008
Bendamustine in patients with rituximab-refractory indolent and transformed non-Hodgkin's lymphoma: results from a phase II multicenter, single-agent study
Jonathan W Friedberg, Philip Cohen, Ling Chen, et al.
The Biochemical Journal
|
January 6, 2011
The role of TBK1 and IKKε in the expression and activation of Pellino 1
Hilary Smith, Xin-Yu Liu, Liang Dai, et al.
Science China. Life Sciences
|
October 24, 2025
Golgi-associated TRAF6 as a regulator of protein convertase FURIN for insulin receptor precursor processing
Minjun Liu, Kun Zhou, Yang Sheng, et al.
Journal of Medicinal Chemistry
|
July 31, 2014
Discovery of type II inhibitors of TGFβ-activated kinase 1 (TAK1) and mitogen-activated protein kinase kinase kinase kinase 2 (MAP4K2)
Li Tan, Tyzoon Nomanbhoy, Deepak Gurbani, et al.
Blood
|
May 5, 2016
HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinib
Guang Yang, Sara J Buhrlage, Li Tan, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 207) with videos related to
Sort By:
Page
of 21
Arthritis and Rheumatism
|
January 22, 2013
Rituximab therapy for primary Sjögren's syndrome: an open-label clinical trial and mechanistic analysis
E William St Clair, Marc C Levesque, Eline T Luning Prak, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 4, 2012
Phosphorylation of CRTC3 by the salt-inducible kinases controls the interconversion of classically activated and regulatory macrophages
Kristopher Clark, Kirsty F MacKenzie, Kasparas Petkevicius, et al.
Chemical Biology & Drug Design
|
June 11, 2013
TAK1 inhibition in the DFG-out conformation
Iain Kilty, Martin P Green, Andrew S Bell, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 27, 2012
Synthesis and structure-activity relationships of a novel series of pyrimidines as potent inhibitors of TBK1/IKKε kinases
Edward G McIver, Justin Bryans, Kristian Birchall, et al.
Journal of the American Chemical Society
|
October 22, 2025
Baited SELEX: Drug-Directed Selection of Aptamers to PSMA for <i>In Vivo</i> Targeting of Prostate Cancer Xenografts in Mice
Kun Liu, Nicole Robinson, Emirhan Tekoglu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 10, 2008
Bendamustine in patients with rituximab-refractory indolent and transformed non-Hodgkin's lymphoma: results from a phase II multicenter, single-agent study
Jonathan W Friedberg, Philip Cohen, Ling Chen, et al.
The Biochemical Journal
|
January 6, 2011
The role of TBK1 and IKKε in the expression and activation of Pellino 1
Hilary Smith, Xin-Yu Liu, Liang Dai, et al.
Science China. Life Sciences
|
October 24, 2025
Golgi-associated TRAF6 as a regulator of protein convertase FURIN for insulin receptor precursor processing
Minjun Liu, Kun Zhou, Yang Sheng, et al.
Journal of Medicinal Chemistry
|
July 31, 2014
Discovery of type II inhibitors of TGFβ-activated kinase 1 (TAK1) and mitogen-activated protein kinase kinase kinase kinase 2 (MAP4K2)
Li Tan, Tyzoon Nomanbhoy, Deepak Gurbani, et al.
Blood
|
May 5, 2016
HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinib
Guang Yang, Sara J Buhrlage, Li Tan, et al.
Page
of 21